CooperCompanies completes strategic review and increases share repurchase authorization to $3 billion
The board retains CooperSurgical, enhances governance with new directors, and launches innovation strategies.
See the latest news and media coverage for CooperCompanies. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global medical device company for vision and reproductive health
coopercos.comLast updated
In short: CooperCompanies completed a strategic review, retaining its surgical unit, while raising its share repurchase program to $3 billion.
The board retains CooperSurgical, enhances governance with new directors, and launches innovation strategies.
It is the first and only soft contact lens proven to slow myopia progression in children aged 8-12.
The report includes first-time Scope 3 greenhouse gas emissions disclosure and expanded performance metrics.
Appointment effective July 1, 2026. Keel, CEO of Envista, joins Audit Committee. His medical device leadership experience aids strategy execution.
In a Form 4 filing with the U.S. Securities and Exchange Commission, Lawrence Kurzius, a Director of...
CooperCompanies reported revenues of $1.07 billion, flat year on year, falling short of analysts' expectations by 2.9%. It was a softer quarter as it posted...
Quick overview Cooper Companies retains CooperSurgical after a strategic review; a sale failed due to management's perspective...
Cooper Companies lowered its annual profit forecast on Wednesday and posted third-quarter revenue below Wall Street estimates, as weak demand for its contact lenses weighed...
Track CooperCompanies and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to CooperCompanies and other trending companies.